US BANCORP \DE\ - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 60 filers reported holding LEAP THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$2,074
-24.4%
6,1000.0%0.00%
Q4 2022$2,745
-45.1%
6,1000.0%0.00%
Q3 2022$5,000
-28.6%
6,1000.0%0.00%
Q2 2022$7,000
-36.4%
6,1000.0%0.00%
Q1 2022$11,000
-45.0%
6,1000.0%0.00%
Q4 2021$20,000
-16.7%
6,1000.0%0.00%
Q3 2021$24,000
+140.0%
6,1000.0%0.00%
Q2 2021$10,000
-16.7%
6,1000.0%0.00%
Q1 2021$12,000
-14.3%
6,1000.0%0.00%
Q4 2020$14,000
+16.7%
6,1000.0%0.00%
Q3 2020$12,000
-7.7%
6,1000.0%0.00%
Q2 2020$13,000
+30.0%
6,1000.0%0.00%
Q1 2020$10,000
+42.9%
6,1000.0%0.00%
Q4 2019$7,0000.0%6,1000.0%0.00%
Q3 2019$7,000
-36.4%
6,1000.0%0.00%
Q2 2019$11,0000.0%6,1000.0%0.00%
Q1 2019$11,000
-8.3%
6,1000.0%0.00%
Q4 2018$12,000
-75.0%
6,1000.0%0.00%
Q3 2018$48,0006,1000.00%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 900,733$1,883,0001.44%
Sio Capital Management, LLC 1,501,998$3,139,0000.92%
CVI Holdings, LLC 704,900$1,473,0000.55%
Perceptive Advisors 8,476,496$17,466,0000.28%
Artal Group S.A. 2,974,000$6,216,0000.17%
SPHERA FUNDS MANAGEMENT LTD. 880,000$1,839,0000.17%
DAFNA Capital Management LLC 275,000$575,0000.17%
J. Goldman & Co LP 1,018,285$2,128,0000.13%
MYDA Advisors LLC 100,000$209,0000.13%
683 Capital Management, LLC 526,466$1,100,0000.09%
View complete list of LEAP THERAPEUTICS INC shareholders